Recall of Medtronic embolization devices classified as most serious by USFDA

Written By :  Ruchika Sharma
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2025-03-20 11:15 GMT   |   Update On 2025-03-20 11:15 GMT

Medtronic's recall of embolization device has been classified most serious by the U.S. Food and Drug Administration (USFDA), citing potential risks of severe injury or death. This decision follows the reports of four patient fatalities.    

As per the USFDA, the affected product could lead to risk of severe adverse health consequences, including thrombosis, stroke, or death.

Thirteen injuries have been reported in connection with the use of the devices known as Pipeline Vantage Embolization devices.

The recall impacts the Pipeline Vantage devices compatible only with 0.027" inner diameter microcatheters, Medtronic said. The company added that it has taken the necessary steps to retrieve the recalled products and has notified regulatory agencies globally as appropriate.

The devices in question are used to treat bulges in the artery walls, or aneurysms, of the brain.
They are inserted into the blood vessels via a small catheter and delivered to the aneurysm site, where a small, braided tube is placed to obstruct blood flow to the bulging area.
The recall involves the withdrawal of the device models from all locations where they are currently in use or for sale, Reuters reported.
Medtronic is recalling the devices following reports of a higher incidence of the flexible, braided tube part of the device failing to properly attach or stay attached to the blood vessel wall during and after procedures involving these devices.
Incomplete wall apposition and braid deformation, also sometimes called fish-mouthing, braid narrowing, or braid collapse, are known risks of these devices, the regulator said, adding that the risks were higher in females, especially those younger than 45 years of age.
Read also: Medtronic receives USFDA clearance for new InPen app featuring missed meal dose detection
Tags:    
Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News